Venture Life Group (VLG) Share Price, News & Analysis

Company Overview

Venture Life is an international consumer self-care company focused on developing and commercialising products for the global self-care market helping our consumers live a longer healthier and more rewarding life. Headquartered in the UK, the Group's product portfolio includes Balance Activ in the area of women's intimate healthcare, Earol® supporting ENT care, Lift and Glucogel product ranges for energy and glucose management and hypoglycaemia, plus the Health & Her product range supporting the hormonal lifecycle. The products, which are typically recommended by pharmacists or healthcare practitioners, are available primarily through health & beauty stores, pharmacies, grocery multiples and e-commerce channels and are sold globally. In the UK, Ireland and the USA these are supplied direct by the company to retailers, elsewhere they are supplied by the Group's international distribution partners.

Key Stats

• Today's Range: 56 to 57
• 50-Day Range: 56.25 to 69.75
• 52-Week Range: 44.50 to 72
• Volume: 304 shs
• Average Volume: 289,729 shs
• Market Capitalization: £68.25 million
• P/E Ratio: 12.81
• Dividend Yield: 0.09%
• Price Target: N/A
• Consensus Rating: N/A

VLG Stock Analysis - Frequently Asked Questions

How have VLG shares performed this year?

Venture Life Group's stock was trading at GBX 65.26 at the beginning of the year. Since then, VLG shares have decreased by 14.2% and is now trading at GBX 56.

How were Venture Life Group's earnings last quarter?

Venture Life Group plc (LON:VLG) released its quarterly earnings data on Tuesday, March, 31st. The company reported ($1.49) earnings per share (EPS) for the quarter. The company had revenue of $35.17 million for the quarter. Venture Life Group had a trailing twelve-month return on equity of 7.82% and a net margin of 17.42%.

How do I buy shares of Venture Life Group?

Shares of VLG stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What other stocks do shareholders of Venture Life Group own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Venture Life Group investors own include Eagle Point Credit (ECC), Antero Resources (AR), Oxford Lane Capital (OXLC), BATM Advanced Communications (BVC), Kape Technologies (KAPE), Litigation Capital Management (LIT) and Meta Platforms (META).

Company Calendar

• Last Earnings: 3/31/2026
• Today: 5/06/2026

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: N/A
• Current Symbol: LON:VLG
• CIK: N/A
• Web: www.venture-life.com
• Phone: +44-1344-742870
• Fax: N/A
• Employees: 165
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): GBX 4.37
• Trailing P/E Ratio: 12.81
• Forward P/E Ratio: 9.12
• P/E Growth: 5.67
• Net Income: £747.21 thousand
• Net Margins: 17.42%
• Pretax Margin: N/A
• Return on Equity: 7.82%
• Return on Assets: 1.56%

Debt

• Debt-to-Equity Ratio: 0.82
• Current Ratio: 4.71
• Quick Ratio: 1.48

Sales & Book Value

• Annual Sales: £35.17 million
• Price / Sales: 1.94
• Cash Flow: GBX 8.76 per share
• Price / Cash Flow: 6.40
• Book Value: GBX 58.74 per share
• Price / Book: 0.95

Miscellaneous

• Outstanding Shares: 121,881,000
• Free Float: N/A
• Market Cap: £68.25 million
• Optionable: Not Optionable
• Beta: 0.32